A retinoic acid receptor β2 agonist attenuates transcriptome and metabolome changes underlying nonalcohol-associated fatty liver disease
2021 · Journal of Biological Chemistry · 23 citations
https://doi.org/10.1016/j.jbc.2021.101331
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
7
Papers
1.3K
Citations
6
h-index
5
i10-index
Changyuan Lu is an academic researcher. The author has contributed to research in topics: Liver Disease Diagnosis and Treatment & Diet, Metabolism, and Disease & Food composition and properties. The author has an h-index of 6, co-authored 6 publications.
ORCID: 0000-0002-4341-3521https://doi.org/10.1016/j.jbc.2021.101331
https://doi.org/10.1073/pnas.2311803121
Click to start Chat